InterCure Announces FY2024 Results and Provides Q1 2025 Update: Revenue of NIS 239 Million and Adjusted EBITDA of NIS 24 Million, Strong Start to 2025

Stock Information for Intercure Ltd.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Intercure Ltd.

InterCure Names Alexander Rabinovich as Chairman Replacing Ehud Barak
InterCure has Secured Funding of NIS 66M to support the recovery of Nir Oz Facility
InterCure Announces First Half of 2024 Results: Revenue of NIS 126 million and Adjusted EBITDA of NIS 21 million
InterCure Announces Expansion of its Strategic partnership with Cookies to Germany
InterCure to Participate in Canaccord Genuity's 8th Annual Global Cannabis Conference
InterCure Announces FY2023 Results: Revenue of NIS 356 million and Adjusted EBITDA of NIS 61 million
InterCure Announces Preliminary Estimated 2023 Revenue of NIS 351 million and EBITDA of over NIS 50 million
InterCure Congratulates Germany on Cannabis Reform, Expanding its Global Footprint

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.